Grants and Contributions:

Back to search

Title:

SARS-CoV-2 ELISA Kits

Agreement Number:

Agreement Value:

$1,014,000.00

Agreement Date:

Jun 18, 2020 - Sep 30, 2021

Description:

Develop immunoassay kits that can measure all three classes of SARS-CoV-2 antibodies simultaneously or individually.

Organization:

National Defence

Expected Results:

The primary objective is to develop an immunoassay that can be used in combination with RT-PCR for COVID-19 diagnosis, can be use to determine which individuals have been infected and have recovered, and can be used with a dry blood spot collection as part of a home test.

Location:

London, Ontario, CA N6M 1A1

Reference Number:

032-2020-2021-Q1-00023

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

123926966R001

Recipient Type:

For-profit organization

Recipient's Operating Name:

Diagnostics BioChem Canada Inc.

Recipient's Legal Name:

Diagnostics BioChem Canada Inc.

Program:

Innovation for Defence Excellence and and Security

Program Purpose:

To encourage the creation of new ideas and formulate solutions to Canada’s current and future defence and security requirements

Coverage:

Canada